Initial Treatment for Chronic Sinusitis
The initial treatment for chronic sinusitis consists of intranasal corticosteroids combined with saline nasal irrigation, both used daily as first-line therapy. 1, 2, 3
First-Line Medical Therapy
Intranasal Corticosteroids
- Intranasal corticosteroids are the cornerstone of treatment due to their anti-inflammatory effects and documented efficacy in relieving nasal congestion, improving overall symptom scores (standardized mean difference -0.46), and reducing polyp size when present. 1, 2, 3
- Fluticasone propionate nasal spray can be used daily for up to 6 months in patients age 12 or older, or up to 2 months per year in children ages 4-11. 4
- These medications work locally in the nose with less than 1% systemic absorption, minimizing side effects even at higher doses. 5
- Relief may begin on the first day, but full effectiveness requires several days of consistent daily use. 4
Saline Nasal Irrigation
- High-volume saline irrigation should be used daily to prevent crusting of secretions and facilitate mechanical removal of mucus. 1, 2, 3
- Hypertonic saline may improve mucociliary clearance more effectively than normal saline. 2
- Saline irrigation improved symptom scores with a standardized mean difference of 1.42 compared to no treatment. 3
Role of Antibiotics
When to Consider Antibiotics
- Antibiotics should NOT be the primary treatment for chronic sinusitis unless there is clear evidence of an active, superimposed acute bacterial infection. 2, 6
- For chronic infectious sinusitis with documented bacterial infection, longer duration therapy (typically 3-4 weeks) may be required with attention to anaerobic pathogens. 1, 2
- Amoxicillin or high-dose amoxicillin-clavulanate are reasonable first choices when bacterial infection is confirmed. 1
- A 3-month course of macrolide antibiotics may be considered specifically for patients WITHOUT nasal polyps who fail first-line therapy. 3
Critical Pitfall to Avoid
- Overuse of antibiotics should be avoided unless there is clear evidence of bacterial infection, as antibiotics play a controversial role in non-infectious chronic sinusitis. 2, 6
Adjunctive Therapies for Symptom Relief
Decongestants
- Topical nasal decongestants (like oxymetazoline) may provide temporary symptomatic relief by widening ostia and reducing turbinate swelling. 2, 7
- Limit use to short-term only (maximum 3 days) to avoid rebound congestion—note that intranasal corticosteroids do NOT cause rebound effects and can be used long-term. 4
Antihistamines
- Consider antihistamines specifically for patients with documented allergic rhinitis as a contributing factor. 2, 7
When to Escalate Treatment
Systemic Corticosteroids
- A short course (1-3 weeks) of oral corticosteroids may be considered for patients with nasal polyps or those failing initial therapy. 1, 3
- Oral prednisolone provides rapid symptomatic improvement and reduces polyp size for approximately 3 months after treatment. 3, 7
Specialist Referral Indications
- Refer to an otolaryngologist when symptoms fail to improve after one week of appropriate first-line therapy, when sinusitis is recurrent, or when it significantly affects quality of life. 2, 4, 6
- Consider referral to an allergist or pulmonologist for patients with suspected underlying conditions such as vasculitides, granulomatous diseases, cystic fibrosis, or immunodeficiency. 6
Treatment Approach Based on Polyp Status
With Nasal Polyps
- Confirm presence or absence of nasal polyps as this is a critical modifying factor for treatment decisions. 1
- Patients with polyps benefit most from intranasal corticosteroids (polyp score improvement standardized mean difference -0.73) and may require systemic corticosteroids or leukotriene antagonists. 1, 3
Without Nasal Polyps
- Focus on intranasal corticosteroids and saline irrigation. 1, 3
- If medical management fails, consider a 3-month course of macrolide antibiotics before surgical intervention. 3
Therapies to AVOID
Antifungal Therapy
- Do NOT prescribe topical or systemic antifungal therapy for chronic sinusitis—multiple randomized controlled trials show lack of efficacy with significant cost and adverse effects. 1